hPD-L1(E3-4)

品系全名

C57BL/6Smoc-Cd274em2(hPD-L1)Smoc

目錄號(hào)

NM-HU-190039

品系狀態(tài)

胚胎凍存

導(dǎo)出PDF

基因信息

基因名
Cd274

品系描述

通過(guò)同源重組,將小鼠基因Cd274進(jìn)行人源化修飾。與此相似的品系還有hPD-L1(NM-HU-00062),詳細(xì)信息請(qǐng)咨詢技術(shù)顧問。
應(yīng)用領(lǐng)域:腫瘤研究;免疫治療;藥物篩選;

驗(yàn)證數(shù)據(jù)

PD-L1-HU-1.png

Fig1.?The expression of human PD-L1 in the peripheral blood cells derived from homozygous humanized mice were confirmed by flow cytometry analysis.?

image.png

Fig2. Immunotype in blood , spleen and bone marrow in hPD-L1 mice.?

image.png

Fig3. Immunotype in blood in hPD-L1 mice.?

image.png


Fig4. Immunotype in spleen in hPD-L1 mice.?

image.png

Fig5. Immunotype in bone marrow in hPD-L1 mice.?

PD-L1-HU-2.png

PD-L1-HU-3.png

Fig6.??In vivo?anti-tumor effect of an anti-human PD-L1 antibody in the humanized PD-L1 mouse model. (Tecentriq is a monoclonal antibody specific for human PD-L1)(A)? PD-L1 humanized MC38 cells were subcutaneously implanted into humanized PD-L1 mouse model. Treatment of hPD-L1 antibody inhibited PD-L1 humanized MC38 tumor growth, demonstrating that the humanized PD-L1 mice are a good in vivo model for validating the efficacy of antibodies targeting human PD-L1. (B) Mean body weight of mice.? All quantitative data are represented as mean ± SEM.


你也可能感興趣

Tamoxifen誘導(dǎo)Cre-ERT2小鼠 使用指南

Cre-ERT2在無(wú)Tamoxifen誘導(dǎo)的情況下,在細(xì)胞質(zhì)內(nèi)處于無(wú)活性狀態(tài);當(dāng)Tamoxifen誘導(dǎo)后,Tamoxifen的代謝產(chǎn)物4-OHT(雌激素類似物)與ERT結(jié)合,可使Cre-ERT2進(jìn)核發(fā)揮Cre重組酶活性。

查看
【小鼠大學(xué)問】基因工程小鼠的命名規(guī)則

常見的基因工程小鼠可以分為兩種命名方式,包括基因定點(diǎn)修飾的小鼠命名,比如:敲除、敲入、點(diǎn)突變等等,和隨機(jī)轉(zhuǎn)基因的小鼠命名。

查看